Bio-Rad Laboratories Inc. (BIO) Tops Q4 EPS Views; Revs Light
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $297.58 --0%
Revenue Growth %: -4.3%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
CCEL, FNGR, FAST, More
Revenue Growth %: -4.3%
Financial Fact:
Cost of goods sold: 236.55M
Today's EPS Names:
CCEL, FNGR, FAST, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q4 EPS of $2.08, $0.41 better than the analyst estimate of $1.67. Revenue for the quarter came in at $550.2 million versus the consensus estimate of $562.06 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- AngioDynamics (ANGO) Tops Q4 EPS by 2c ; Offers Guidance
- BofA Securities Downgrades Sylvamo Corp. (SLVM) to Neutral
- KeyBanc Highlights Crescent Energy (CRGY) Into Earnings
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
